Dr. Bruce Strober earned his medical and doctorate degrees from Columbia University in New York, New York. He subsequently completed his residency in dermatology in the Department of Dermatology at New York University School of Medicine in New York, New York. He is board certified by the American Board of Dermatology and a Fellow of the American Academy of Dermatology.
Dr. Strober’s research interests include the study of old and new therapeutics for inflammatory skin disease, specifically interventions that help patients with difficult-to-treat psoriasis, atopic dermatitis, and hidradenitis suppurativa. Additional research interests include the elucidation of novel features of inflammatory skin disease not previously uncovered and assisting in clarifying the pathophysiology of inflammatory skin disease. He has served as principal investigator or sub-investigator for numerous multicenter clinical studies.
Dr. Strober is a Clinical Professor of Dermatology at Yale University School of Medicine. He is currently the Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis. Dr. Strober has served as a Section Editor for the British Journal of Dermatology and an ad hoc reviewer for the Journal of the American Academy of Dermatology, JAMA Dermatology, the British Journal of Dermatology, and the New England Journal of Medicine. He has published more than 200 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, the New England Journal of Medicine, the Journal of the American Academy of Dermatology, the Journal of Investigative Dermatology, and the Journal of the American Medical Association, among others. Dr. Strober has frequently presented data to the FDA, including at the advisory committee for secukinumab, a novel IL-17 inhibitor for treating psoriasis. He currently is the Vice President/President-Elect and Treasurer on the Board of the International Psoriasis Council and Scientific Co-Director of the CorEvitas Psoriasis Registry.
His primary clinical focus is the treatment of difficult-to-treat inflammatory diseases of the skin, such as psoriasis, atopic dermatitis, and hidradenitis suppurativa.
Before co-founding Central Connecticut Dermatology, Dr. Strober was Professor and Chair in the Department of Dermatology, University of Connecticut School of Medicine in Farmington, Connecticut.